Get started
Dr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADRDr. Reddy's Laboratories Ltd. Sponsored ADR

Dr. Reddy's Laboratories Ltd. Sponsored ADR

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

RDDA trade ideas

DRREDDY in BUY modeFundamentally a STRONG company and it had recent news for its upmove Dr Reddy's Laboratories has expanded strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and distribute three of Amgen's medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, the company will commercialise XGEVA'(denosumab), Vectibix' (panitumumab) and Prolia (donosumab) in India. The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016. The promoters holding in the company stood at 26.37%, while institutions and non-institutions held 41.16% and 15.64% respectively. Dr. Reddy’s Laboratories has been listed as an Index component of the Dow Jones Sustainability Indices (DJSI) 2016 in the Pharmaceuticals, Biotechnology & Life Sciences Industry Group. The pharma major has been recognized for its corporate sustainability leadership and is the only pharmaceutical company on the Index of Emerging Markets. The listing was based on 22 criterion, with Dr. Reddy’s receiving high scores for Product Quality and Recall Management, Codes of Business Conduct, Environmental Reporting, Corporate Citizenship and Philanthropy.
NSE:DRREDDYLong
by agan
Dr Reddy's Lab Stock Is Technically Challenged - 7/25/2016India's one of the biggest drug maker is going to release quarterly results soon and its stock is already feeling the jitters. Analysts and news papers will annotate the appropriate headline but someone who is aware about the technicals will of course be taking profit at this levels. A solid up trend from the beginning of 2009 is still in effect but it is going to be challenged soon. Sock price is random but they usually don't stop at random points which you can surmise by looking that attached charts. Even a huge drop from 4400 stopped at 2800. Well, that is not a coincidence for sure. Good stocks should always be traded with long bias and long side is more rewarding in long term for stocks ! But nothing wrong in taking profit time to time when you feel that the run has enough. We have been actively trading Dr Reddy with amalgamation of stocks, options and futures. So right now we have deployed our favorite strategy of selling covered calls on long positions. After Dr Reddy's quarterly result release tomorrow, following levels are going to be very interesting and this is how we are planning to trade it. Near 4000 / 4200 resistance - Covered call selling on most positions with liquidation of stocks too. And probably switch to short side by buying puts. 3200 / 3000 support - cover existing covered calls and trading it from buy side. Indian pharma trade is very simple. Buy when FDA helps us to get it with bargain and sell when all is good and stock starts sputter at lofty heights. Our other recent pharma trade, Cipla Limited longs are looking very promising and we may add to the position during dips targetting 560 / 600.
NSE:DRREDDY
by BombayBulls